• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.16% Nasdaq Down0.08%

    PDL BioPharma, Inc. (PDLI)

    -NasdaqGS
    6.13 Down 0.28(4.37%) Jul 2, 4:00PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
    Total Revenue 581,225   456,260   380,880  
    Cost of Revenue -   -   -  
    Gross Profit 581,225   456,260   380,880  
    Operating Expenses
    Research Development -   -   -  
    Selling General and Administrative34,914  29,755  25,469  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss 546,311   426,505   355,411  
    Income from Continuing Operations
    Total Other Income/Expenses Net(5,828)242  758  
    Earnings Before Interest And Taxes540,483  426,747  356,169  
    Interest Expense39,211  24,871  29,036  
    Income Before Tax501,272  401,876  327,133  
    Income Tax Expense179,028  137,346  115,464  
    Minority Interest -   -   -  
    Net Income From Continuing Ops316,101  264,530  211,669  
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income 322,244   264,530   211,669  
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares 322,244   264,530   211,669  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.